Incyte IDO combo | PVCT Message Board Posts

Provectus Biopharmaceuticals, Inc.

  PVCT website
  • Create your FREE account today!



    Username:Up to 23 characters, no spaces or apostrophes allowed.

    Password:6-20 characters.

    Confirm PasswordRetype Your Password.

    Email:You will receive an email to confirm this account,so please enter a valid address (and double cheek for typos!)


    I have read and agree to the InvestorVillage User Agreement.













PVCT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  31697 of 38110  at  6/13/2016 4:33:42 PM  by

canis_star


Incyte IDO combo

Incyte is also started pivotal combo trial with its IDO inhibitor and Pembrolizumab for Stage III and IV Melanoma (600 patients).

https://clinicaltrials.gov/ct2/show/study/NCT02752074?term=neuroendocrine+cancer&show_locs=Y#locn

Race is on.... hopefully we will catch them up since we might have fewer patients in PV-10 combo trial. Amgen and Incyte have deep pockets and will aggressively add trial sites and recruit patients.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 259
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
31699 Re: Incyte IDO combo canis_star 3 6/13/2016 4:44:24 PM
31700 Re: Incyte IDO combo vorlon1966 0 6/13/2016 4:55:29 PM
31705 Re: Incyte IDO combo vorlon1966 6 6/13/2016 5:53:16 PM


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2016 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.

Loading...